• Je něco špatně v tomto záznamu ?

Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders

K.R. Raja, L. Kovarova, R. Hajek

. 2010 ; 149 (3) : 334-351. [pub] 20100301

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc12025146

Grantová podpora
NS10406 MZ0 CEP - Centrální evidence projektů
NS10408 MZ0 CEP - Centrální evidence projektů

Flow cytometric immunophenotyping is considered an indispensable tool for the diagnosis, classification and monitoring of disease in monoclonal gammopathies. The clinical sensitivity of flow cytometry is comparable with advanced molecular methods. Clinical application of flow cytometry in monoclonal gammopathies has various dimensions, such as differential diagnosis of malignant plasma cell disorder from reactive plasmacytosis, identifying the progression risk in monoclonal gammopathy of undetermined significance (MGUS) and asymptomatic multiple myeloma (MM), and minimal residual disease detection. Flow cytometry-based clonality assessment with immunophenotyping encourages and enables the most stringent method of diagnosis and follow-up. The objective of this review is to update the malignant plasma cells phenotypic profile of MGUS and MM. The most comprehensive antigens, such as CD19, CD27, CD28, CD45, CD56 and CD117, play a significant role in the characterization of normal and malignant plasma cells. Several research groups described the putative phenotype of myeloma cell progenitors, but no remarkable suggestion could be made because of disparity. This review also focuses on the association of malignant phenotypic markers and chromosomal aberrations that identify the specific prognostic features in monoclonal gammopathies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12025146
003      
CZ-PrNML
005      
20141219115250.0
007      
ta
008      
120816e20100301enk f 000 0#eng||
009      
AR
024    7_
$a 10.1111/j.1365-2141.2010.08121.x $2 doi
035    __
$a (PubMed)20201947
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Raja, Karthick R M $u University Research Centre-Czech Myeloma Group, Kamenice 5, Bohunice, Brno 62500, Czech Republic. rajakarthick594@gmail.com
245    10
$a Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders / $c K.R. Raja, L. Kovarova, R. Hajek
520    9_
$a Flow cytometric immunophenotyping is considered an indispensable tool for the diagnosis, classification and monitoring of disease in monoclonal gammopathies. The clinical sensitivity of flow cytometry is comparable with advanced molecular methods. Clinical application of flow cytometry in monoclonal gammopathies has various dimensions, such as differential diagnosis of malignant plasma cell disorder from reactive plasmacytosis, identifying the progression risk in monoclonal gammopathy of undetermined significance (MGUS) and asymptomatic multiple myeloma (MM), and minimal residual disease detection. Flow cytometry-based clonality assessment with immunophenotyping encourages and enables the most stringent method of diagnosis and follow-up. The objective of this review is to update the malignant plasma cells phenotypic profile of MGUS and MM. The most comprehensive antigens, such as CD19, CD27, CD28, CD45, CD56 and CD117, play a significant role in the characterization of normal and malignant plasma cells. Several research groups described the putative phenotype of myeloma cell progenitors, but no remarkable suggestion could be made because of disparity. This review also focuses on the association of malignant phenotypic markers and chromosomal aberrations that identify the specific prognostic features in monoclonal gammopathies.
650    _2
$a antigeny nádorové $x metabolismus $7 D000951
650    _2
$a biologické markery $x metabolismus $7 D015415
650    _2
$a diferenciální diagnóza $7 D003937
650    _2
$a průtoková cytometrie $x metody $7 D005434
650    _2
$a lidé $7 D006801
650    _2
$a imunofenotypizace $x metody $7 D016130
650    _2
$a monoklonální gamapatie nejasného významu $x diagnóza $x imunologie $7 D008998
650    _2
$a mnohočetný myelom $x diagnóza $x imunologie $7 D009101
650    _2
$a plazmatické buňky $x imunologie $7 D010950
650    _2
$a nádorové biomarkery $x metabolismus $7 D014408
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Říhová, Lucie $7 xx0081970
700    1_
$a Hájek, Roman, $d 1964- $7 nlk20000083645
773    0_
$w MED00009374 $t British journal of haematology $x 1365-2141 $g Roč. 149, č. 3 (20100301), s. 334-351
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20201947 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20141219115403 $b ABA008
999    __
$a ok $b bmc $g 947188 $s 782492
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 149 $c 3 $d 334-351 $e 20100301 $i 1365-2141 $m British journal of haematology $n Br J Haematol $x MED00009374
GRA    __
$a NS10406 $p MZ0
GRA    __
$a NS10408 $p MZ0
LZP    __
$a Pubmed-20120816/10/02

Najít záznam

Citační ukazatele

Možnosti archivace